Comparative bioequivalence study in healthy volunteers under fasting conditions. research hub

Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Test Product Apixaban 5 mg film-coated tablets (MEDITOP) with the Reference Product Eliquis 5 mg film-coated tablets (Bristol-Myers Squibb/Pfizer) under fasting conditions.

This study compares two different brands of apixaban 5mg tablets. It checks if a new generic version (Test Product) works the same way in the body as the original one (Eliquis). Healthy volunteers take one dose while fasting to see how the medication is absorbed.